MARKET

OCUP

OCUP

Ocuphire Pharma Inc
NASDAQ
3.890
-0.070
-1.77%
After Hours: 3.990 +0.1 +2.57% 20:05 09/21 EDT
OPEN
3.940
PREV CLOSE
3.960
HIGH
3.957
LOW
3.850
VOLUME
179.62K
TURNOVER
0
52 WEEK HIGH
6.60
52 WEEK LOW
1.900
MARKET CAP
81.72M
P/E (TTM)
5.47
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at OCUP last week (0911-0915)?
Weekly Report · 3d ago
5 Value Stocks In The Healthcare Sector
Benzinga · 09/11 14:44
Weekly Report: what happened at OCUP last week (0904-0908)?
Weekly Report · 09/11 10:01
Weekly Report: what happened at OCUP last week (0828-0901)?
Weekly Report · 09/04 17:04
Biotech Stocks Facing FDA Decision In September 2023
NASDAQ · 08/31 13:30
Weekly Report: what happened at OCUP last week (0821-0825)?
Weekly Report · 08/28 10:04
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 08/18 15:20
Cantor Fitzgerald Reiterates Ocuphire Pharma (OCUP) Overweight Recommendation
NASDAQ · 08/14 19:51
More
About OCUP
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its pipeline includes two small molecule product candidates targeting several of such indications. Nyxol Eye Drops (Nyxol) is a once-daily eye drop formulation of phentolamine mesylate designed to reduce pupil diameter and improve visual acuity. Nyxol can potentially be used across multiple indications such as treatment of pharmacologically induced mydriasis (RM), presbyopia (age-related blurry near vision) and dim light or night vision disturbances (DLD) (halos, glares and starbursts). Its product candidate, APX3330, is a twice-a-day oral tablet designed to target multiple pathways relevant to retinal and choroidal (the vascular layer of the eye) diseases. The Company has also in-licensed APX2009 and APX2014, which are second-generation product candidates and analogs of APX3330.

Webull offers kinds of Ocuphire Pharma Inc stock information, including NASDAQ:OCUP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCUP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OCUP stock methods without spending real money on the virtual paper trading platform.